Showing results (51-60 of 217) with videos related to

Sort By:
Pageof 22
Anticancer Research|December 26, 2012
Genistein and daidzein: different molecular effects on prostate cancerMawussi Adjakly, Marjolaine Ngollo, Jean-Paul Boiteux, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 2, 2002
Expression of BRCA1 and BRCA2 in different tumor cell lines with various growth statusCécile Vissac, Monique Peffault De Latour, Yves Communal, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 23, 2015
Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkersInsaf Fkih M'hamed, Maud Privat, Flora Ponelle, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 12, 2011
Peripheral blood DNA methylation detected in the BRCA1 or BRCA2 promoter for sporadic ovarian cancer patients and controlsRémy Bosviel, Emilie Michard, Guillaume Lavediaux, et al.
Trials|October 23, 2016
BRACAVENIR - impact of a psychoeducational intervention on expectations and coping in young women (aged 18-30 years) exposed to a high familial breast/ovarian cancer risk: study protocol for a randomized controlled trialFabrice Kwiatkowski, Pascal Dessenne, Claire Laquet, et al.
Pathology Oncology Research : POR|January 20, 2017
miR-10b, miR-26a, miR-146a And miR-153 Expression in Triple Negative Vs Non Triple Negative Breast Cancer: Potential BiomarkersInsaf Fkih M'hamed, Maud Privat, Mounir Trimeche, et al.
Congenital Anomalies|February 21, 2019
Association between hereditary predisposition to common cancers and congenital multimalformationsFabrice Kwiatkowski, Isabelle Perthus, Nancy Uhrhammer, et al.
Pharmacogenomics|August 5, 2006
Gene signature of breast cancer cell lines treated with lycopeneNasséra Chalabi, Laëtitia Delort, Ludovic Le Corre, et al.
Anticancer Research|January 2, 2010
Central adiposity as a major risk factor of ovarian cancerLaetitia Delort, Fabrice Kwiatkowski, Nassera Chalabi, et al.
Anticancer Research|May 1, 2007
Risk factors for early age at breast cancer onset--the "COSA program" population-based studyLaetitia Delort, Fabrice Kwiatkowski, Nasséra Chalabi, et al.
Pageof 22